CompletedNCT00330174
Acamprosate or placebo for alcohol use with anxiety or depression
About this title
Acamprosate in Alcoholics With Comorbid Anxiety or Depression
Read the official source — NCT00330174Medication studyAges 18–60United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- Belmont and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 90
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00330174
- Official title
Show the full official title
The Use of Acamprosate in Individuals With Alcohol Dependence and Comorbid Anxiety or Depression
Get this study by email
Recruitment & locations
CompletedBelmont · New York · Pickens
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Did this study involve medication?
Yes. The study involved medication, including Acamprosate.
Who was this study for?
Listed age limits: 18 years to 60 years.
